Cargando…

Academia–Pharma Intersect: Providing a Broader Perspective on Drug Development Synergies between Academia and Industry

Detalles Bibliográficos
Autor principal: Chabner, Bruce A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227880/
https://www.ncbi.nlm.nih.gov/pubmed/20086167
http://dx.doi.org/10.1634/theoncologist.2009-0338
_version_ 1782217791284183040
author Chabner, Bruce A.
author_facet Chabner, Bruce A.
author_sort Chabner, Bruce A.
collection PubMed
description
format Online
Article
Text
id pubmed-3227880
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher AlphaMed Press
record_format MEDLINE/PubMed
spelling pubmed-32278802012-04-25 Academia–Pharma Intersect: Providing a Broader Perspective on Drug Development Synergies between Academia and Industry Chabner, Bruce A. Oncologist Editorials AlphaMed Press 2010-01 /pmc/articles/PMC3227880/ /pubmed/20086167 http://dx.doi.org/10.1634/theoncologist.2009-0338 Text en ©AlphaMed Press available online without subscription through the open access option.
spellingShingle Editorials
Chabner, Bruce A.
Academia–Pharma Intersect: Providing a Broader Perspective on Drug Development Synergies between Academia and Industry
title Academia–Pharma Intersect: Providing a Broader Perspective on Drug Development Synergies between Academia and Industry
title_full Academia–Pharma Intersect: Providing a Broader Perspective on Drug Development Synergies between Academia and Industry
title_fullStr Academia–Pharma Intersect: Providing a Broader Perspective on Drug Development Synergies between Academia and Industry
title_full_unstemmed Academia–Pharma Intersect: Providing a Broader Perspective on Drug Development Synergies between Academia and Industry
title_short Academia–Pharma Intersect: Providing a Broader Perspective on Drug Development Synergies between Academia and Industry
title_sort academia–pharma intersect: providing a broader perspective on drug development synergies between academia and industry
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227880/
https://www.ncbi.nlm.nih.gov/pubmed/20086167
http://dx.doi.org/10.1634/theoncologist.2009-0338
work_keys_str_mv AT chabnerbrucea academiapharmaintersectprovidingabroaderperspectiveondrugdevelopmentsynergiesbetweenacademiaandindustry